These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006. Gabbay E; Reed A; Williams TJ Intern Med J; 2007 Jan; 37(1):38-48. PubMed ID: 17199843 [TBL] [Abstract][Full Text] [Related]
25. [Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension]. Osvaldo Cáneva J; Ossés JM Medicina (B Aires); 2003; 63(3):233-6. PubMed ID: 12876911 [TBL] [Abstract][Full Text] [Related]
26. Prostacyclin therapy for pulmonary arterial hypertension: new directions. Gomberg-Maitland M; Preston IR Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316 [TBL] [Abstract][Full Text] [Related]
29. When cure is care: diagnosis and management of pulmonary arterial hypertension. Widmar B J Am Acad Nurse Pract; 2005 Mar; 17(3):104-12. PubMed ID: 15748223 [TBL] [Abstract][Full Text] [Related]
30. Use of prostacyclin and its analogues in the treatment of cardiovascular disease. Fink AN; Frishman WH; Azizad M; Agarwal Y Heart Dis; 1999; 1(1):29-40. PubMed ID: 11720602 [TBL] [Abstract][Full Text] [Related]
31. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension]. Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337 [No Abstract] [Full Text] [Related]
32. Recent advances in the treatment of pediatric pulmonary artery hypertension. Barst RJ Pediatr Clin North Am; 1999 Apr; 46(2):331-45. PubMed ID: 10218078 [TBL] [Abstract][Full Text] [Related]
33. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501 [TBL] [Abstract][Full Text] [Related]
34. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension]. Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363 [No Abstract] [Full Text] [Related]
35. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension. Park MH Catheter Cardiovasc Interv; 2008 Feb; 71(2):205-13. PubMed ID: 18327839 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation. Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R Respiration; 2016; 91(1):9-17. PubMed ID: 26492415 [TBL] [Abstract][Full Text] [Related]
37. Survival of patients with idiopathic pulmonary arterial hypertension after listing for transplantation: impact of iloprost and bosentan treatment. Dandel M; Lehmkuhl HB; Mulahasanovic S; Weng Y; Kemper D; Grauhan O; Knosalla C; Hetzer R J Heart Lung Transplant; 2007 Sep; 26(9):898-906. PubMed ID: 17845928 [TBL] [Abstract][Full Text] [Related]
38. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension. Tonelli AR; Alnuaimat H; Mubarak K Respir Med; 2010 Apr; 104(4):481-96. PubMed ID: 20004088 [TBL] [Abstract][Full Text] [Related]
39. Emerging medical therapies for pulmonary arterial hypertension. Galiè N; Manes A; Branzi A Prog Cardiovasc Dis; 2002; 45(3):213-24. PubMed ID: 12525997 [TBL] [Abstract][Full Text] [Related]
40. Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. Fattouch K; Sbraga F; Bianco G; Speziale G; Gucciardo M; Sampognaro R; Ruvolo G J Card Surg; 2005; 20(2):171-6. PubMed ID: 15725144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]